ARTICLE | Company News
Inhibitex, 3M deal
January 8, 2007 8:00 AM UTC
MMM received an exclusive worldwide license to INHX's ClfA protein target for developing diagnostics. MMM also received a license to additional INHX MCSCRAMM protein targets, which are located on the...